The biocompatible 3D printing materials is forecast to explosive growth over the next few years. According to the WK-chem Research "Global Biocompatible 3D Printing Materials Professional Survey Report 2022, Forecast to 2027", With the rapid growth of the pharmaceutical industry and the advancement of medical technology, the biocompatible 3D printing materials industry is developing at a rapid speed. The compound annual growth rate (CAGR) for the 2022-2027 period is projected to be 20% base on WK-chem Research regression analysis model.
Analysts' Viewpoint
"The rapid expansion of the pharmaceutical industry in recent years has increased investment in medical technology, and the biocompatible 3D printing materials industry will further expand the market in the future because of its obvious performance advantages." said Jordan King, Senior analyst, Chemical & Material Market Research Center in WK-chem Research. "But the high price of biocompatible 3D printing materials is the main factor limiting its future development."
Market insight
Compared with traditional products, biocompatible 3D printing materials has excellent performance and a wide range of applicable scenarios. Because of the particularity of its material and the precision of 3D printing technology, the patient's survival rate can be significantly improved after implantation. And the porosity of 3D-printed objects, along with their ability to match user anatomy and provide a high level of customization, makes biocompatible 3D printing materials a broad prospect in the implant and prosthetic industry. In some areas, due to the continued aggravation of population aging and the continuous Increase in the number of elderly people, biocompatible 3D printing materials will have a wide range of application scenarios in these areas. In addition to the advantages of biocompatible 3D printing materials products, the production process of biocompatible 3D printing materials is more efficient than traditional materials, and because of the biocompatibility of biocompatible 3D printing materials, it is more environmentally friendly in the product life cycle. Analysts believe that the excellent performance of biocompatible 3D printing materials products is the fundamental factor that promotes its development. Because of its excellent performance, the medical industry has also increased its demand for biocompatible 3D printing materials in recent years, which is the main factor to promote its development. The rapid expansion of the medical industry around the world has increased the investment and research and development capabilities of medical-related industries, including industries with high technical barriers such as biocompatible 3D printing materials. Early biocompatible 3D printing materials had limited applications, mostly due to dental and skeletal implants. With the explosive development of printing technology and new materials in recent years, the application scope of biocompatible 3D printing materials has been further expanded to various flexible tissues and organs of the human body. It is expected that with the continuous increase of investment in the medical industry, biocompatible 3D printing materials technology will continue to develop rapidly in the future, which will further expand biocompatible 3D printing materials in the future. In addition, increased government investment in 3D printing is an important potential for the business. But developing FDA-approved 3D printing biomaterials and creating low-cost 3D printing materials are the two biggest challenges facing the industry. Biocompatible 3D printing materials high production costs and producing government-approved products are the main limiting factors. Analysts believe that this will be an urgent problem for biocompatible 3D printing materials companies to solve in the process of developing new technologies, and companies that are the first to produce newer products that are safer and more economical can occupy a larger market share.
Competition Landscape
: This WK-chem Research market report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biocompatible 3D printing materials companies that include Evonik Industries AG, Renishaw PLC, Formlabs Inc, Concept Laser GmBH, 3D Systems, Inc, EOS GmBH Electro-Optical Systems, Stratasys Ltd, EnvisionTEC, 3D Composites, aspect Biosystems. The 3D Systems, Inc. introduced its new 3D printer, NextDent 5100, which is specifically designed for dental labs. The printer is a breakthrough in digital density due to its capabilities and cost efficiency.
Market Segmentation
: Based on Type, The market is segmented into Polymer, Metal, and Others. The increased demand for polymer, which is cheaper, easier to mold, and degradable, is driving the rise of this market. Based on Form, The market is segmented into Powder, Liquid and Others. Printing materials in powder form will be the fastest growing material form in the future due to their cheaper and easier transportation features. Based on Application, The market is segmented into Implants & Prosthesis, Prototyping & Surgical Guides, Tissue Engineering, Hearing Aids, Others. The tissue engineering application segment holds the highest proportion of the worldwide biocompatible 3D printing materials market. The increased cases of tissue or organ failure due to age, diseases, accidents, and congenital defects, as well as the expansion in research & development on bio fabrication of body parts and organ printing, are driving the growth of this segment. Biocompatible 3D Printing Materials
Regional Market Analysis
:
In terms of geography, the global biocompatible 3D printing materials market has been segmented into: North America, Asia Pacific, Europe, South America, and the Middle East and Africa. Throughout the projected period, North America is expected to lead the market. The region's primary driving element in the global market is increasing government spending in 3D printing, well-established research and development facilities, an increase in the number of businesses, and a strong economy to support research financing. During the projected period, Asia-Pacific is expected to have the highest CAGR in the global market. Manufacturers are investing in the development of biocompatible 3D printing materials, and increased demand for biocompatible 3D printing materials in developing nations, as well as rising healthcare awareness, are projected to boost the market growth.
Cagr: 20%
Region with the largest share: North America
Largest country in largest share region: The Unite States
Product Type(by Type): Polymer, Metal, Others
Product Type(by Form): Powder, Liquid, Others
Application: Implants & Prosthesis, Prototyping & Surgical Guides, Tissue Engineering, Hearing Aids, Others
Leading Company: Evonik Industries AG, Renishaw PLC, Formlabs Inc, Concept Laser GmBH, 3D Systems, Inc
